(1S,4R,7S,12R,14S,17S,20S,23S,31R)-17-[(2R)-butan-2-yl]-27-[(1S,4R,7R,12R,14R,17S,20S,23S,31R)-17-[(2S)-butan-2-yl]-12,31-dihydroxy-20-[(1R)-1-hydroxyethyl]-2,5,8,15,18,21-hexaoxo-4,7-di(propan-2-yl)-6-oxa-3,9,10,16,19,22,24-heptazapentacyclo[20.10.0.09,14.023,31.025,30]dotriaconta-25(30),26,28-trien-28-yl]-12,31-dihydroxy-20-[(1S)-1-hydroxyethyl]-4,7-di(propan-2-yl)-6-oxa-3,9,10,16,19,22,24-heptazapentacyclo[20.10.0.09,14.023,31.025,30]dotriaconta-25(30),26,28-triene-2,5,8,15,18,21-hexone

Details

Top
Internal ID 6c9521f8-236a-4436-8f59-1a7a749d4677
Taxonomy Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides
IUPAC Name (1S,4R,7S,12R,14S,17S,20S,23S,31R)-17-[(2R)-butan-2-yl]-27-[(1S,4R,7R,12R,14R,17S,20S,23S,31R)-17-[(2S)-butan-2-yl]-12,31-dihydroxy-20-[(1R)-1-hydroxyethyl]-2,5,8,15,18,21-hexaoxo-4,7-di(propan-2-yl)-6-oxa-3,9,10,16,19,22,24-heptazapentacyclo[20.10.0.09,14.023,31.025,30]dotriaconta-25(30),26,28-trien-28-yl]-12,31-dihydroxy-20-[(1S)-1-hydroxyethyl]-4,7-di(propan-2-yl)-6-oxa-3,9,10,16,19,22,24-heptazapentacyclo[20.10.0.09,14.023,31.025,30]dotriaconta-25(30),26,28-triene-2,5,8,15,18,21-hexone
SMILES (Canonical) CCC(C)C1C(=O)NC(C(=O)N2C(CC3(C2NC4=C3C=CC(=C4)C5=CC6=C(C=C5)NC7C6(CC8N7C(=O)C(NC(=O)C(NC(=O)C9CC(CNN9C(=O)C(OC(=O)C(NC8=O)C(C)C)C(C)C)O)C(C)CC)C(C)O)O)O)C(=O)NC(C(=O)OC(C(=O)N2C(CC(CN2)O)C(=O)N1)C(C)C)C(C)C)C(C)O
SMILES (Isomeric) CC[C@@H](C)[C@H]1C(=O)N[C@H](C(=O)N2[C@@H](C[C@@]3([C@H]2NC4=C3C=CC(=C4)C5=CC6=C(C=C5)N[C@@H]7[C@]6(C[C@@H]8N7C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]9C[C@H](CNN9C(=O)[C@H](OC(=O)[C@H](NC8=O)C(C)C)C(C)C)O)[C@@H](C)CC)[C@@H](C)O)O)O)C(=O)N[C@@H](C(=O)O[C@H](C(=O)N2[C@@H](C[C@H](CN2)O)C(=O)N1)C(C)C)C(C)C)[C@H](C)O
InChI InChI=1S/C72H104N14O20/c1-15-33(11)51-61(95)81-53(35(13)87)63(97)83-47(59(93)77-49(29(3)4)67(101)105-55(31(7)8)65(99)85-45(57(91)79-51)23-39(89)27-73-85)25-71(103)41-19-17-38(22-44(41)76-69(71)83)37-18-20-43-42(21-37)72(104)26-48-60(94)78-50(30(5)6)68(102)106-56(32(9)10)66(100)86-46(24-40(90)28-74-86)58(92)80-52(34(12)16-2)62(96)82-54(36(14)88)64(98)84(48)70(72)75-43/h17-22,29-36,39-40,45-56,69-70,73-76,87-90,103-104H,15-16,23-28H2,1-14H3,(H,77,93)(H,78,94)(H,79,91)(H,80,92)(H,81,95)(H,82,96)/t33-,34+,35+,36-,39-,40-,45+,46-,47+,48+,49-,50-,51+,52+,53+,54+,55+,56-,69+,70+,71-,72-/m1/s1
InChI Key DHAIKQCMNDLVSH-JTXALRIGSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C72H104N14O20
Molecular Weight 1485.70 g/mol
Exact Mass 1484.75513176 g/mol
Topological Polar Surface Area (TPSA) 478.00 Ų
XlogP 3.40
Atomic LogP (AlogP) -2.40
H-Bond Acceptor 24
H-Bond Donor 16
Rotatable Bonds 11

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,4R,7S,12R,14S,17S,20S,23S,31R)-17-[(2R)-butan-2-yl]-27-[(1S,4R,7R,12R,14R,17S,20S,23S,31R)-17-[(2S)-butan-2-yl]-12,31-dihydroxy-20-[(1R)-1-hydroxyethyl]-2,5,8,15,18,21-hexaoxo-4,7-di(propan-2-yl)-6-oxa-3,9,10,16,19,22,24-heptazapentacyclo[20.10.0.09,14.023,31.025,30]dotriaconta-25(30),26,28-trien-28-yl]-12,31-dihydroxy-20-[(1S)-1-hydroxyethyl]-4,7-di(propan-2-yl)-6-oxa-3,9,10,16,19,22,24-heptazapentacyclo[20.10.0.09,14.023,31.025,30]dotriaconta-25(30),26,28-triene-2,5,8,15,18,21-hexone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8509 85.09%
Caco-2 - 0.8602 86.02%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Mitochondria 0.4431 44.31%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8449 84.49%
OATP1B3 inhibitior + 0.9260 92.60%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior + 0.9487 94.87%
P-glycoprotein inhibitior + 0.7420 74.20%
P-glycoprotein substrate + 0.8105 81.05%
CYP3A4 substrate + 0.7124 71.24%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8078 80.78%
CYP3A4 inhibition - 0.8425 84.25%
CYP2C9 inhibition - 0.6938 69.38%
CYP2C19 inhibition - 0.6972 69.72%
CYP2D6 inhibition - 0.8851 88.51%
CYP1A2 inhibition - 0.8151 81.51%
CYP2C8 inhibition + 0.6627 66.27%
CYP inhibitory promiscuity - 0.8247 82.47%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.8600 86.00%
Carcinogenicity (trinary) Non-required 0.5586 55.86%
Eye corrosion - 0.9838 98.38%
Eye irritation - 0.8957 89.57%
Skin irritation - 0.7802 78.02%
Skin corrosion - 0.9307 93.07%
Ames mutagenesis - 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7270 72.70%
Micronuclear + 0.8900 89.00%
Hepatotoxicity + 0.5427 54.27%
skin sensitisation - 0.8482 84.82%
Respiratory toxicity + 0.7556 75.56%
Reproductive toxicity + 0.8889 88.89%
Mitochondrial toxicity + 0.9250 92.50%
Nephrotoxicity - 0.6236 62.36%
Acute Oral Toxicity (c) III 0.5690 56.90%
Estrogen receptor binding + 0.5507 55.07%
Androgen receptor binding + 0.7742 77.42%
Thyroid receptor binding + 0.7706 77.06%
Glucocorticoid receptor binding + 0.8250 82.50%
Aromatase binding + 0.7862 78.62%
PPAR gamma + 0.8036 80.36%
Honey bee toxicity - 0.7199 71.99%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.6200 62.00%
Fish aquatic toxicity + 0.8843 88.43%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.19% 96.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 99.06% 85.14%
CHEMBL2581 P07339 Cathepsin D 98.60% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 97.61% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.41% 97.09%
CHEMBL1937 Q92769 Histone deacetylase 2 93.81% 94.75%
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.89% 97.25%
CHEMBL1806 P11388 DNA topoisomerase II alpha 89.37% 89.00%
CHEMBL1949 P62937 Cyclophilin A 88.98% 98.57%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.93% 86.33%
CHEMBL1075162 Q13304 Uracil nucleotide/cysteinyl leukotriene receptor 88.58% 80.33%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.52% 91.11%
CHEMBL2842 P42345 Serine/threonine-protein kinase mTOR 86.88% 92.78%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.76% 97.14%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 86.41% 95.89%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 86.19% 90.71%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.91% 95.89%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 85.79% 93.03%
CHEMBL255 P29275 Adenosine A2b receptor 85.44% 98.59%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 85.13% 93.40%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.93% 100.00%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 83.66% 93.04%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.44% 95.56%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 82.67% 91.03%
CHEMBL202 P00374 Dihydrofolate reductase 80.04% 89.92%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 163103831
LOTUS LTS0159696
wikiData Q104979695